BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9579237)

  • 61. Bone mineral density in geriatric patients with toxic nodular goiter.
    Sahin SB; Ayaz T; Sumer F; İlkkilic K; Algun E
    Aging Clin Exp Res; 2015 Apr; 27(2):221-6. PubMed ID: 25161096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.
    Philippou G; Koutras DA; Piperingos G; Souvatzoglou A; Moulopoulos SD
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):573-8. PubMed ID: 1424182
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bone mineral density in postmenopausal women treated with L-thyroxine.
    Adlin EV; Maurer AH; Marks AD; Channick BJ
    Am J Med; 1991 Mar; 90(3):360-6. PubMed ID: 2003518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
    Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine.
    Slawik M; Klawitter B; Meiser E; Schories M; Zwermann O; Borm K; Peper M; Lubrich B; Hug MJ; Nauck M; Olschewski M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4115-22. PubMed ID: 17711927
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term thyroxine treatment and bone mineral density.
    Franklyn JA; Betteridge J; Daykin J; Holder R; Oates GD; Parle JV; Lilley J; Heath DA; Sheppard MC
    Lancet; 1992 Jul; 340(8810):9-13. PubMed ID: 1351654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats.
    Gouveia CH; Jorgetti V; Bianco AC
    J Bone Miner Res; 1997 Dec; 12(12):2098-107. PubMed ID: 9421243
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin.
    Ongphiphadhanakul B; Alex S; Braverman LE; Baran DT
    J Bone Miner Res; 1992 Oct; 7(10):1227-31. PubMed ID: 1456090
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation.
    Leonova TA; Drozd VM; Saenko VA; Mine M; Biko J; Rogounovitch TI; Takamura N; Reiners C; Yamashita S
    Endocr J; 2015; 62(2):173-82. PubMed ID: 25374130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
    Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
    Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time.
    Olkawa M; Kushida K; Takahashi M; Ohishi T; Hoshino H; Suzuki M; Ogihara H; Ishigaki J; Inoue T
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):171-6. PubMed ID: 10396358
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
    Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies.
    Yang R; Yao L; Fang Y; Sun J; Guo T; Yang K; Tian L
    J Bone Miner Metab; 2018 Mar; 36(2):209-220. PubMed ID: 28357593
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bone mineral density is reduced in female but not male subjects with Addison's disease.
    Florkowski CM; Holmes SJ; Elliot JR; Donald RA; Espiner EA
    N Z Med J; 1994 Feb; 107(972):52-3. PubMed ID: 8115069
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW; Yeung SS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.
    Hawkins F; Rigopoulou D; Papapietro K; Lopez MB
    Calcif Tissue Int; 1994 Jan; 54(1):16-9. PubMed ID: 8118747
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment.
    Eftekhari M; Asadollahi A; Beiki D; Izadyar S; Gholamrezanezhad A; Assadi M; Fard-Esfahani A; Fallahi B; Takavar A; Saghari M
    Hell J Nucl Med; 2008; 11(3):160-3. PubMed ID: 19081859
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bone mass in females with different thyroid disorders: influence of menopausal status.
    Campos-Pastor MM; Muñoz-Torres M; Escobar-Jiménez F; Ruiz de Almodóvar M; Jódar Gimeno E
    Bone Miner; 1993 Apr; 21(1):1-8. PubMed ID: 8324416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.